RMD

ResMed
D

RMD

Arincen97/100B

ResMed debt to equity ratio

ResMed's debt to equity ratio is 0.10: total debt of 610.58M USD against shareholders' equity of 5.95B USD.

Today
0.10
Average, 5 years
0.24
Low, 5 years
0.10
High, 5 years
0.52

Debt to equity = total debt ÷ shareholders' equity = 610.58M ÷ 5.95B = 0.10

Debt to equity
Total debt
Shareholders' equity

Total debt over shareholders' equity at each quarter end.

Debt to equity by year and by quarter

Fiscal yearPeriod endingDebt to equityTotal debtShareholders' equity
Today0.10610.58M5.95B
FY202630 Jun 20260.13825.92M6.59B
FY202530 Jun 20250.14851.81M5.97B
FY202430 Jun 20240.18873.94M4.86B
FY202330 Jun 20230.381.58B4.13B
FY202230 Jun 20220.27917.55M3.36B
FY202130 Jun 20210.28793.72M2.89B
FY202030 Jun 20200.521.30B2.50B
FY201930 Jun 20190.611.27B2.07B
FY201830 Jun 20180.14281.45M2.06B
FY201730 Jun 20170.551.08B1.96B
FY201630 Jun 20160.691.17B1.69B
FY201530 Jun 20150.19300.59M1.59B
FY201430 Jun 20140.17300.79M1.76B
FY201330 Jun 20130.19300.79M1.61B
FY201230 Jun 20120.16250.84M1.61B
FY201130 Jun 20110.06100.16M1.73B
FY201030 Jun 20100.09121.69M1.29B
FY200930 Jun 20090.15161.74M1.12B
FY200830 Jun 20080.13137.65M1.08B
FY200730 Jun 20070.12116.00M931.22M
FY200630 Jun 20060.16121.08M738.15M
FY200530 Jun 20050.37174.37M474.07M
FY200430 Jun 20040.31113.25M361.50M
FY200330 Jun 20030.40113.25M286.43M
FY200230 Jun 20020.64123.25M192.93M
FY200130 Jun 20011.49150.00M100.37M
FY200030 Jun 20000.000.0093.97M
FY199930 Jun 19990.000.0071.60M
FY199830 Jun 19980.00200.00K50.80M
FY199730 Jun 19970.01600.00K44.60M
FY199630 Jun 19960.02900.00K39.00M
FY199530 Jun 19950.03800.00K28.90M
FY199430 Jun 19940.07400.00K5.60M
FY199330 Jun 19930.10300.00K2.90M

Figures in USD. A quarter's revenue, net income and dividends are those of its last four quarters.

See also:P/E ratio,Market cap,P/S ratio,Dividend yield,ROE (return on equity),Current ratio,All ratios

Common questions about ResMed's debt to equity

Source: Financial Modeling Prep

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.